-transparent.png){kind=logo}
[Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital]. 1994
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
Servicio de Urología, Complejo Hospitalario San Millan-San Pedro, Logroño, La Rioja.
Report of a retrospective study to evaluate susceptibility of Escherichia coli to quinolones covering the March-December 1992 interval. During this time, intra and extra-hospital strains were indistinctly studied in patients with urinary infections seen in a health district serving a total of 200.000 inhabitants. Resistance to Pipemidic acid, Norfloxacin and Ciprofloxacin was evaluated. The values found were 14.8% resistance to Pipemidic acid, 11.1% to Norfloxacin and 8.5% to Ciprofloxacin. It seems necessary to develop and apply methods addressed to minimize the appearance of quinolone resistance, which should be implemented in order to preserve the usefulness of these drugs.
Related Publications
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
February 2008,
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
June 2017,
Central European journal of public health,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
July 2001,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
January 2019,
Infection and drug resistance,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
October 2002,
The Journal of infectious diseases,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
January 1988,
Molecular & general genetics : MGG,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
November 1999,
Antimicrobial agents and chemotherapy,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
January 2019,
Infection and drug resistance,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
February 1989,
Antimicrobial agents and chemotherapy,
A Fernández Fernández, and
M Lantero Benedito, and
M J Gastañares Hernando, and
E Undabeitia Santisteban, and
F Fernández Santos, and
A Castaño Rodríguez, and
J Gil Fabra, and
F Martínez Castellanos, and
G Otero Mauricio
August 2016,
Scientific reports,
